4569.T
KYORIN Pharmaceutical Co., Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2026-03-31

Average Intrinsic Value

527.07M USD

Market Cap

390.54M USD

Margin of Safety

25.9%

Intrinsic / Market Ratio

1.35×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

356.06M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

333.23M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

891.93M USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

527.07M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

527.07M USD

from the sum above

Market Cap

390.54M USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

1.35×

the ratio the screener ranks by; Margin of Safety +25.9% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 356.06M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)410.57M USD
−②Net Debt Today54.51M USD
+③Growth Value0 USD
=Value356.06M USD

EPV of the Operations (NOPAT over WACC)

410.57M USD

Net debt today

-54.51M USD

Growth Value

0 USD

Value

356.06M USD

①EPV (earnings power value)

410.57M USD

②Net Debt Today

54.51M USD

③Growth Value

0 USD

Market value

Market Cap390.54M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-9.7%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 333.23M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE111.55M USD
+②Equity at Year 15, Today221.67M USD
=Value333.23M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

111.55M USD

②Equity at Year 15, Today

221.67M USD

Market value

Market Cap390.54M USD

The price on the date above times the shares.

Value vs market

Margin of Safety-17.2%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 891.93M USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (a change in working capital above half the operating profit in the latest three years), so the value is the book value today, 891.93M USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Debt Today

Not in the value

Market value

Market Cap390.54M USD

The price on the date above times the shares.

Value vs market

Margin of Safety+56.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.83%
Cost of Equity =Risk-Free Rate 4.50%+Beta (default) 1.00×Market Risk Premium 6.00%= 10.50%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 6.27M USDPretax Income 27.87M USD= 22.51%

The tax the interest saves.

Interest Expense =EBIT 29.46M USD−Pretax Income 27.87M USD= 1.59M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 1.59M USDTotal Debt 148.95M USD×(1 − Tax Rate for WACC 22.51%)= 0.83%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 148.95M USDMarket Cap + Total Debt 390.54M USD + 148.95M USD= 27.61%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 72.39%×Cost of Equity 10.50%+Debt Weight 27.61%×Cost of Debt 0.83%= 7.83%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 1.22B USD − Total Liabilities 332.10M USD = Book Value Today 891.93M USD

Total Debt 148.95M USD − Cash and Short-Term Investments 94.44M USD = Net Debt Today 54.51M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-0.0%at most 5%passes57,446,295 / 57,448,785
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets1.5%at least -10.0%passes(39.96M USD − 21.59M USD) ÷ 1.22B USD
Price to bookMarket Cap ÷ Book Value Today0.44×at most 3×passes390.54M USD ÷ 891.93M USD
Operating marginOperating Income ÷ Revenue2.8%above 10.0%does not pass22.34M USD ÷ 790.68M USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-9.2%above 10.0%does not pass790.68M USD / 870.34M USD
Net cash(Cash − Total Debt) ÷ Market Cap-19.2%above -30%passes(73.91M USD − 148.95M USD) ÷ 390.54M USD
Operating efficiencyOperating Income ÷ Gross Profit6.9%above 25.0%does not pass22.34M USD ÷ 323.28M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

1066.06 JPY

Enterprise value

67.54B JPY

the provider's own figure

EV / EBITDA

9.95×

Price / book

0.44×

the provider's book

Price / earnings

17.73×

Return on equity

1.6%

the provider's figure, not this page's

Profit margin

1.7%

Revenue growth

-1.9%

Analyst target, mean

1101.10 JPY

Analysts

1

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2023202420252026
Income statement

Revenue

851.22M790.09M870.34M790.68M

Gross profit

377.00M341.25M398.31M323.28M

Operating income

38.51M41.21M84.09M22.34M

EBITDA

operating income before depreciation and amortisation

81.25M76.64M117.39M58.67M

Pretax income

51.90M47.85M85.44M27.87M

Net income

35.49M36.19M60.79M21.59M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

29.57M33.57M63.02M19.84M

R&D

————
Balance sheet, year end

Total assets

1.32B1.17B1.30B1.22B

Total liabilities

380.14M309.96M383.59M332.10M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

942.83M864.13M911.80M891.93M

Total debt

159.90M138.45M190.27M148.95M

Cash and equivalents

145.75M91.78M100.50M73.91M

Net PP&E

fixed assets after depreciation

194.14M191.36M202.74M191.04M

Working capital

current assets less current liabilities

631.61M487.47M675.89M662.41M
Cash flow

Operating cash flow

15.09M10.24M23.46M39.96M

Capital expenditure

paid out, so below zero

-70.68M-41.29M-42.10M-24.90M

Depreciation and amortisation

28.86M28.36M30.80M29.20M

Free cash flow

operating cash flow plus capital expenditure

-55.59M-31.05M-18.65M15.06M